- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07684989
Comparison of Low-Dose Versus Standard-Dose Hyperbaric Bupivacaine in Spinal Anesthesia
Comparison of Low-Dose Versus Standard-Dose Hyperbaric Bupivacaine in Spinal Anesthesia: Hemodynamic Stability and Recovery Profile in Elderly Patients Undergoing Lower Limb Orthopedic Surgery
The goal of this randomized controlled trial is to determine whether low-dose hyperbaric bupivacaine provides better hemodynamic stability and postoperative recovery compared with standard-dose hyperbaric bupivacaine in elderly patients undergoing lower limb orthopedic surgery under spinal anesthesia.
The main questions it aims to answer are:
- Does low-dose hyperbaric bupivacaine reduce the incidence of intraoperative hypotension and bradycardia compared with standard-dose hyperbaric bupivacaine?
- Does low-dose hyperbaric bupivacaine improve postoperative recovery profile compared with standard-dose hyperbaric bupivacaine?
Researchers will compare elderly patients receiving low-dose hyperbaric bupivacaine with those receiving standard-dose hyperbaric bupivacaine to determine whether a lower intrathecal dose improves cardiovascular stability and recovery without compromising the effectiveness of spinal anesthesia.
Participants will:
- Provide written informed consent before enrollment.
- Undergo elective lower limb orthopedic surgery under spinal anesthesia.
- Be randomly assigned to receive either low-dose or standard-dose hyperbaric bupivacaine.
- Have their blood pressure, heart rate, and other vital signs monitored throughout the surgical procedure.
- Be assessed for intraoperative hypotension and bradycardia according to predefined study criteria.
- Be evaluated for postoperative recovery parameters, including motor recovery and readiness for postoperative recovery and mobilization.
The information obtained from this study may help identify a safer and more effective spinal anesthetic technique for elderly patients undergoing orthopedic surgery.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Fase 4
Contatti e Sedi
Contatto studio
- Nome: Muhammad Shaheryar Bashir, MBBS, BSc, FCPS (R) CHPE, DPHN
- Numero di telefono: +92-335-4377900
- Email: drmsb259@gmail.com
Luoghi di studio
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54950
- Mayo Hospital, Lahore
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Male or female patients aged 65 years and above.
- Patients scheduled for elective lower limb orthopedic surgery under spinal anesthesia.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Patients willing to participate and provide written informed consent.
Exclusion Criteria:
- Refusal to participate in the study.
- Contraindications to spinal anesthesia (e.g., infection at puncture site, coagulopathy, severe hypovolemia, raised intracranial pressure).
- Known hypersensitivity or allergy to bupivacaine.
- Severe valvular heart disease.
- Significant cardiac arrhythmias.
- Uncontrolled hypertension.
- Severe hepatic or renal impairment.
- Pre-existing neurological disorders affecting lower limb motor or sensory function.
- Severe spinal deformity or previous lumbar spine surgery interfering with spinal anesthesia.
- Cognitive impairment or inability to provide informed consent.
- Emergency orthopedic procedures.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Low-Dose Hyperbaric Bupivacaine
Participants randomized to this group will receive low-dose hyperbaric bupivacaine for spinal anesthesia before elective lower limb orthopedic surgery.
Hemodynamic parameters and postoperative recovery outcomes will be assessed according to the study protocol.
|
Low-dose hyperbaric bupivacaine administered intrathecally for spinal anesthesia in elderly patients undergoing elective lower limb orthopedic surgery.
|
|
Comparatore attivo: Standard-Dose Hyperbaric Bupivacaine
Participants randomized to this group will receive standard-dose hyperbaric bupivacaine for spinal anesthesia before elective lower limb orthopedic surgery.
Hemodynamic parameters and postoperative recovery outcomes will be assessed according to the study protocol.
|
Standard-dose hyperbaric bupivacaine administered intrathecally for spinal anesthesia in elderly patients undergoing elective lower limb orthopedic surgery.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of Intraoperative Hypotension
Lasso di tempo: From administration of spinal anesthesia until completion of surgery
|
Occurrence of intraoperative hypotension following spinal anesthesia, defined as a decrease in systolic blood pressure greater than 20% from baseline or systolic blood pressure less than 90 mmHg requiring intervention.
|
From administration of spinal anesthesia until completion of surgery
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of Intraoperative Bradycardia
Lasso di tempo: From administration of spinal anesthesia until completion of surgery.
|
Occurrence of intraoperative bradycardia, defined as heart rate less than 50 beats per minute requiring pharmacological treatment.
|
From administration of spinal anesthesia until completion of surgery.
|
|
Time to Complete Motor Recovery
Lasso di tempo: From completion of surgery until achievement of Bromage Score 0, assessed up to 24 hours postoperatively
|
Time required to achieve complete motor recovery following spinal anesthesia, assessed using Bromage Score 0.
|
From completion of surgery until achievement of Bromage Score 0, assessed up to 24 hours postoperatively
|
|
Time to First Ambulation
Lasso di tempo: Within the first 24 hours after surgery
|
Time from completion of surgery to the patient's first assisted ambulation.
|
Within the first 24 hours after surgery
|
|
Postoperative Recovery Profile
Lasso di tempo: From completion of surgery until discharge from the post-anesthesia care unit (PACU), assessed up to 24 hours postoperatively
|
Assessment of recovery following spinal anesthesia, including readiness for discharge from the post-anesthesia care unit and return of motor function.
|
From completion of surgery until discharge from the post-anesthesia care unit (PACU), assessed up to 24 hours postoperatively
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Lee YY, Ngan Kee WD, Muchhal K, Chan CK. Clinical comparison of 12 mg ropivacaine and 8 mg bupivacaine (with fentanyl) in spinal anaesthesia for major orthopaedic surgery in geriatric patients. Acta Anaesthesiol Scand. 2011;55(3):298-303
- Ben-David B, Frankel R, Arzumonov T, Marchevsky Y, Volpin G. Minidose bupivacaine-fentanyl spinal anesthesia for surgical repair of hip fracture in the aged. Anesthesiology. 2000 Jan;92(1):6-10. doi: 10.1097/00000542-200001000-00007.
- Patel A, Yadav AK, Patel PS, Kumari R, Deepesh. Comparative hemodynamic stability in low-dose versus conventional-dose bupivacaine for spinal anaesthesia in elderly patients. Int J Pharm Res Technol. 2025;15(2). doi:10.31838/ijprt/15.2.89.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- Mayo_ANS_01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .